Clinical Trials Logo

Insulin Resistance - Type B clinical trials

View clinical trials related to Insulin Resistance - Type B.

Filter by:
  • None
  • Page 1

NCT ID: NCT04221152 Active, not recruiting - Clinical trials for Insulin Resistance Syndrome

A Extension Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance ( EMPIRE-02 )

EMPIRE-02
Start date: February 1, 2020
Phase: Phase 3
Study type: Interventional

A multicenter, open-label, single-arm, extension study with regard to the safety and efficacy of empagliflozin in patients with refractory diabetes mellitus with insulin resistance.

NCT ID: NCT04018365 Active, not recruiting - Clinical trials for Insulin Resistance Syndrome

A Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance

EMPIRE-01
Start date: September 1, 2019
Phase: Phase 3
Study type: Interventional

A multicenter, open-label, single-arm study with regard to the efficacy and safety of empagliflozin in patients with refractory diabetes mellitus with insulin resistance